Europe Custom Antibody Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The Europe custom antibody services market is projected to grow significantly, reaching approximately US$ 395.31 million by 2031, up from US$ 194.22 million in 2023, with a compound annual growth rate (CAGR) of 9.3% during the forecast period.

Executive Summary and Market Analysis

The custom antibody services market in Europe is on a steady upward trajectory, primarily driven by the rising demand for personalized medicine, advancements in oncology and neurology research, and the growth of the biotech and pharmaceutical industries. Key European nations, including Germany, the UK, and France, are at the forefront of this growth due to their robust research infrastructure and substantial funding support. The increasing emphasis on targeted therapies and the adoption of recombinant antibodies are also significant factors contributing to market expansion. Furthermore, collaborations between academic institutions and contract research organizations (CROs) are fostering innovation, while regulatory support and technological advancements bolster Europe's competitive edge in the global custom antibody services market.

Market Segmentation Analysis

The Europe custom antibody services market can be segmented based on product type, service type, application, disease indication, source, and end user:

Product Type: The market is divided into monoclonal, polyclonal, hybridoma, recombinant antibodies, and others. In 2023, monoclonal antibodies held the largest market share.
Service Type: This segment includes antibody discovery and development, antibody production services, and others, with antibody discovery and development leading in market share in 2023.
Application: The applications include immunohistochemistry, western blotting & immunoprecipitation (IP), ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. ELISA was the dominant application in 2023.
Disease Indication: The market is segmented into oncology, infectious diseases, immunology, cardiovascular diseases, and others, with oncology being the largest segment in 2023.
Source: This includes chicken, rabbits, rats, guinea pigs, mouse or humanized mice, and others. The mouse or humanized mice segment had the largest share in 2023, further divided into various antibody platforms.
End User: The end users comprise the life science industry, pharmaceutical and biotech companies, academic and research institutes, and contract research organizations, with the life science industry leading in market share in 2023.

Market Outlook

Emerging countries are increasingly launching research and development initiatives focused on genomics and proteomics, with Europe making notable progress in genomics research through various initiatives and funding programs. The 1+ Million Genomes (1+MG) initiative, initiated in 2018, aims to enhance access to genomic and health data across Europe, supported by a €20 million grant for the Genome of Europe project. The Horizon Europe program, along with its predecessor Horizon 2020, has funded numerous genomics projects, including QUANTOMICS, which focuses on livestock genomics. Additionally, the Marie Sklodowska-Curie Actions (MSCA) provides €6.6 billion in fellowships for interdisciplinary research, including genomics, while EU4Health, with a budget of €5.1 billion, supports healthcare initiatives related to genomics. The rise in government-backed research initiatives is expected to create lucrative opportunities for the custom antibody services market in the coming years.

Country Insights

The Europe custom antibody services market includes countries such as the UK, Germany, France, Italy, Spain, and others, with Germany holding the largest market share in 2023. The anticipated growth in Germany is attributed to the increasing prevalence of chronic diseases, particularly cancer, which is a leading cause of morbidity and mortality. According to the World Health Organization (WHO), Germany reported 628,519 new cancer cases and 252,065 deaths in 2020. The rising cancer incidence drives the demand for targeted therapies, where custom antibodies can play a crucial role in improving treatment efficacy and minimizing side effects.

For instance, in September 2023, AMSBIO provided a custom monoclonal antibody to researchers at the Technical University Dortmund to study the role of EDI3 in breast cancer development, demonstrating the practical applications of custom antibodies in research.

The presence of various market players in Germany, such as BioGenes GmbH, which offers a wide range of custom antibodies and services, further supports market growth. The company is involved in product innovation and development, providing antibodies targeting various proteins and small molecules.

Company Profiles

Key players in the custom antibody services market include Thermo Fisher Scientific Inc., Sino Biological Inc., GenScript Biotech Corporation, Biochain Incorporated, R&D Systems, Inc., and others. These companies are employing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their customers.

Product Code: BMIRE00032162

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Custom Antibody Services Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Europe Custom Antibody Services Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Rising Approvals of Biosimilars
5.2 Market Restraints
- 5.2.1 High Costs and Complexities Associated with Antibody Production Using Transgenic Animals
5.3 Market Opportunities
- 5.3.1 Rise in Government Research and Development Activities in Emerging and Developed Economies
5.4 Future Trends
- 5.4.1 Technological Advancements Using Recombinant Antibodies
5.5 Impact of Drivers and Restraints:

6. Custom Antibody Services Market - Europe Analysis

6.1 Europe Custom Antibody Services Market Revenue (US$ Million), 2021-2031
6.2 Europe Custom Antibody Services Market Forecast Analysis

7. Europe Custom Antibody Services Market Analysis - by End User

7.1 Life Science Industry
- 7.1.1 Overview
- 7.1.2 Life Science Industry: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Pharmaceutical and Biotech Companies
- 7.2.1 Overview
- 7.2.2 Pharmaceutical and Biotech Companies: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Academic and Research Institutes
- 7.3.1 Overview
- 7.3.2 Academic and Research Institutes: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Contract Research Organizations
- 7.4.1 Overview
- 7.4.2 Contract Research Organizations: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Custom Antibody Services Market Analysis - by Disease Indication

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Infectious Diseases
- 8.2.1 Overview
- 8.2.2 Infectious Diseases: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Immunology
- 8.3.1 Overview
- 8.3.2 Immunology: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Cardiovascular Diseases
- 8.4.1 Overview
- 8.4.2 Cardiovascular Diseases: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Custom Antibody Services Market Analysis - by Source

9.1 Chicken
- 9.1.1 Overview
- 9.1.2 Chicken: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Rabbits
- 9.2.1 Overview
- 9.2.2 Rabbits: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Rats
- 9.3.1 Overview
- 9.3.2 Rats: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Guinea Pigs
- 9.4.1 Overview
- 9.4.2 Guinea Pigs: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5 Mouse or Humanized Mice
- 9.5.1 Overview
- 9.5.2 Mouse or Humanized Mice: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Custom Antibody Services Market Analysis - by Mouse or Humanized Mice

10.1 Monoclonal Antibody Platform
- 10.1.2 Monoclonal Antibody Platform: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2 BsAb Discovery Platform
- 10.2.2 BsAb Discovery Platform: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Bispecific ADC Platform
- 10.3.2 Bispecific ADC Platform: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4 TCR-Mimic Antibody Platform
- 10.4.2 TCR-Mimic Antibody Platform: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5 Anti-GPCR Antibody Technology Platform
- 10.5.2 Anti-GPCR Antibody Technology Platform: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6 Others
- 10.6.2 Others: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. Europe Custom Antibody Services Market Analysis - by Application

11.1 Immunohistochemistry (IHC)
- 11.1.1 Overview
- 11.1.2 Immunohistochemistry (IHC): Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.2 Western Blot and IP
- 11.2.1 Overview
- 11.2.2 Western Blot and IP: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3 ELISA
- 11.3.1 Overview
- 11.3.2 ELISA: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4 Fluorescence-activated cell sorting (FACS)
- 11.4.1 Overview
- 11.4.2 Fluorescence-activated cell sorting (FACS): Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.5 Mass Spectrometry
- 11.5.1 Overview
- 11.5.2 Mass Spectrometry: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.6 Others
- 11.6.1 Overview
- 11.6.2 Others: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

12. Europe Custom Antibody Services Market Analysis - by Service Type

12.1 Antibody Discovery and Development
- 12.1.1 Overview
- 12.1.2 Antibody Discovery and Development: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2 Antibody Production Services
- 12.2.1 Overview
- 12.2.2 Antibody Production Services: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3 Others
- 12.3.1 Overview
- 12.3.2 Others: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

13. Europe Custom Antibody Services Market Analysis - by Product Type

13.1 Monoclonal
- 13.1.1 Overview
- 13.1.2 Monoclonal: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.2 Polyclonal hybridoma
- 13.2.1 Overview
- 13.2.2 Polyclonal hybridoma: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.3 Recombinant antibody
- 13.3.1 Overview
- 13.3.2 Recombinant antibody: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.4 Others
- 13.4.1 Overview
- 13.4.2 Others: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

14. Europe Custom Antibody Services Market - Country Analysis

14.1 Europe
- 14.1.1 Europe Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
  - 14.1.1.1 Europe Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
  - 14.1.1.2 United Kingdom: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.2.1 United Kingdom: Europe Custom Antibody Services Market Share - by End User
    - 14.1.1.2.2 United Kingdom: Europe Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.2.3 United Kingdom: Europe Custom Antibody Services Market Share - by Source
    - 14.1.1.2.4 United Kingdom: Europe Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.2.5 United Kingdom: Europe Custom Antibody Services Market Share - by Application
    - 14.1.1.2.6 United Kingdom: Europe Custom Antibody Services Market Share - by Service Type
    - 14.1.1.2.7 United Kingdom: Europe Custom Antibody Services Market Share - by Product Type
  - 14.1.1.3 Germany: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.3.1 Germany: Europe Custom Antibody Services Market Share - by End User
    - 14.1.1.3.2 Germany: Europe Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.3.3 Germany: Europe Custom Antibody Services Market Share - by Source
    - 14.1.1.3.4 Germany: Europe Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.3.5 Germany: Europe Custom Antibody Services Market Share - by Application
    - 14.1.1.3.6 Germany: Europe Custom Antibody Services Market Share - by Service Type
    - 14.1.1.3.7 Germany: Europe Custom Antibody Services Market Share - by Product Type
  - 14.1.1.4 France: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.4.1 France: Europe Custom Antibody Services Market Share - by End User
    - 14.1.1.4.2 France: Europe Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.4.3 France: Europe Custom Antibody Services Market Share - by Source
    - 14.1.1.4.4 France: Europe Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.4.5 France: Europe Custom Antibody Services Market Share - by Application
    - 14.1.1.4.6 France: Europe Custom Antibody Services Market Share - by Service Type
    - 14.1.1.4.7 France: Europe Custom Antibody Services Market Share - by Product Type
  - 14.1.1.5 Italy: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.5.1 Italy: Europe Custom Antibody Services Market Share - by End User
    - 14.1.1.5.2 Italy: Europe Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.5.3 Italy: Europe Custom Antibody Services Market Share - by Source
    - 14.1.1.5.4 Italy: Europe Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.5.5 Italy: Europe Custom Antibody Services Market Share - by Application
    - 14.1.1.5.6 Italy: Europe Custom Antibody Services Market Share - by Service Type
    - 14.1.1.5.7 Italy: Europe Custom Antibody Services Market Share - by Product Type
  - 14.1.1.6 Spain: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.6.1 Spain: Europe Custom Antibody Services Market Share - by End User
    - 14.1.1.6.2 Spain: Europe Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.6.3 Spain: Europe Custom Antibody Services Market Share - by Source
    - 14.1.1.6.4 Spain: Europe Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.6.5 Spain: Europe Custom Antibody Services Market Share - by Application
    - 14.1.1.6.6 Spain: Europe Custom Antibody Services Market Share - by Service Type
    - 14.1.1.6.7 Spain: Europe Custom Antibody Services Market Share - by Product Type
  - 14.1.1.7 Rest of Europe: Europe Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.7.1 Rest of Europe: Europe Custom Antibody Services Market Share - by End User
    - 14.1.1.7.2 Rest of Europe: Europe Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.7.3 Rest of Europe: Europe Custom Antibody Services Market Share - by Source
    - 14.1.1.7.4 Rest of Europe: Europe Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.7.5 Rest of Europe: Europe Custom Antibody Services Market Share - by Application
    - 14.1.1.7.6 Rest of Europe: Europe Custom Antibody Services Market Share - by Service Type
    - 14.1.1.7.7 Rest of Europe: Europe Custom Antibody Services Market Share - by Product Type

15. Custom Antibody Services Market - Industry Landscape

15.1 Overview
15.2 Growth Strategies in Custom Antibody Services Market
15.3 Organic Growth Strategies
- 15.3.1 Overview
15.4 Inorganic Growth Strategies
- 15.4.1 Overview

16. Company Profiles

16.1 Thermo Fisher Scientific Inc
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 Sino Biological Inc.
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 GenScript Biotech Corporation
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Biochain Incorporated
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 R&D Systems, Inc
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 Kaneka Eurogentec S.A.
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Fortis Life Sciences
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Precision Antibody (A&G Pharmaceutical, Inc.)
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 Biocytogen Pharmaceuticals Beijing Co Ltd
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Abgenex
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments
16.11 Creative Biolabs Inc
- 16.11.1 Key Facts
- 16.11.2 Business Description
- 16.11.3 Products and Services
- 16.11.4 Financial Overview
- 16.11.5 SWOT Analysis
- 16.11.6 Key Developments
16.12 Agilent Technologies Inc
- 16.12.1 Key Facts
- 16.12.2 Business Description
- 16.12.3 Products and Services
- 16.12.4 Financial Overview
- 16.12.5 SWOT Analysis
- 16.12.6 Key Developments
16.13 Bioklone
- 16.13.1 Key Facts
- 16.13.2 Business Description
- 16.13.3 Products and Services
- 16.13.4 Financial Overview
- 16.13.5 SWOT Analysis
- 16.13.6 Key Developments
16.14 Scantibodies Laboratory, Inc.
- 16.14.1 Key Facts
- 16.14.2 Business Description
- 16.14.3 Products and Services
- 16.14.4 Financial Overview
- 16.14.5 SWOT Analysis
- 16.14.6 Key Developments

17. Appendix

17.1 About The Insight Partners
17.2 Glossary of Terms